Gut Microbiome Components Predict Response to Neoadjuvant Therapy in HER2-positive Breast Cancer Patients : A Prospective Study
Status: RECRUITING
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: PROCEDURE: stool and blood collection
Sponsor: The First Affiliated Hospital with Nanjing Medical University